Diseases, Conditions, Syndromes

Patient critical after reinfection with S.African variant: study

Doctors in France are treating a critically ill patient infected with the South African coronavirus variant, four months after he recovered from COVID-19, in what study authors said was the first case of its kind.

Diseases, Conditions, Syndromes

Pfizer/BioNTech first dose 85% effective after 2-4 weeks: study

The first dose of the Pfizer/BioNTech vaccination is 85 percent effective against coronavirus infection between two and four weeks after inoculation, according to a study published in the Lancet medical journal.

Oncology & Cancer

A new approach to averting inflammation caused by COVID-19

Severe COVID-19 illness can result in excessive inflammation throughout the body, including the lungs, heart and brain. University of Minnesota Twin Cities student Molly Gilligan recently published an article in the journal ...

Diseases, Conditions, Syndromes

Killer fungus spread rampantly at US hospital COVID ward: study

Dozens of people being treated for COVID-19 at a Florida hospital last summer became additionally infected with a mysterious, often deadly fungus called Candida auris, a US government study said Friday.

Diseases, Conditions, Syndromes

Most coronavirus infections are mild, says Chinese study

Most people infected by the new coronavirus in China have mild symptoms, with older patients and those with underlying conditions most at risk from the disease, according to a study by Chinese researchers.

page 1 from 34